Sinopharm (1099.HK) breaks above the declining channel
Medion Jim December 10, 2020 2:00 PM
Sinopharm's (1099.HK), a Chinese pharmaceutical company, Covid-19 vaccine achieved a 86% efficacy in trials conducted in the United Arab Emirates...
Sinopharm's (1099.HK), a Chinese pharmaceutical company, Covid-19 vaccine achieved a 86% efficacy in trials conducted in the United Arab Emirates, according to UAE's Ministry of Health and Prevention. In addition, the company is also waiting for the approval of the China regulator to release the vaccine in China.
From a technical point of view, the stock broke above a declining channel. In addition, the bullish cross between 20-day and 50-day moving averages has been identified. Both technical events would suggest the bullish reversal signal. Hence, bullish readers should set the support level at HK$17.80, while the resistance levels would be located at HK$20.50 and HK$21.80.
Source: GAIN Capital, TradingView
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.